These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38626078)

  • 1. Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention.
    Spirito A; Krishnan SL; Capodanno D; Angiolillo DJ; Mehran R
    Circ Cardiovasc Interv; 2024 Apr; 17(4):e013263. PubMed ID: 38626078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring antiplatelet therapy in older patients with coronary artery disease.
    Kovacevic M; Pompei G; Kunadian V
    Platelets; 2023 Dec; 34(1):2285446. PubMed ID: 38050696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?
    Sabouret P; Spadafora L; Fischman D; Ullah W; Zeitouni M; Gulati M; De Rosa S; Savage MP; Costabel JP; Banach M; Biondi-Zoccai G; Galli M
    Eur J Intern Med; 2023 Apr; 110():1-9. PubMed ID: 36575107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Holdt L; Felix SB; Parma R; Klopotowski M; Schwinger RHG; Rieber J; Huber K; Neumann FJ; Koltowski L; Mehilli J; Huczek Z; Massberg S;
    Lancet; 2017 Oct; 390(10104):1747-1757. PubMed ID: 28855078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial.
    Li Y; Jing Q; Wang B; Wang X; Li J; Qiao S; Chen S; Angiolillo DJ; Han Y
    Am Heart J; 2020 Oct; 228():1-7. PubMed ID: 32739652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis.
    Tavenier AH; Mehran R; Chiarito M; Cao D; Pivato CA; Nicolas J; Beerkens F; Nardin M; Sartori S; Baber U; Angiolillo DJ; Capodanno D; Valgimigli M; Hermanides RS; van 't Hof AWJ; Ten Berg JM; Chang K; Kini AS; Sharma SK; Dangas G
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):492-502. PubMed ID: 34459481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
    Harris J; Pouwels KB; Johnson T; Sterne J; Pithara C; Mahadevan K; Reeves B; Benedetto U; Loke Y; Lasserson D; Doble B; Hopewell-Kelly N; Redwood S; Wordsworth S; Mumford A; Rogers C; Pufulete M
    Health Technol Assess; 2023 May; 27(8):1-257. PubMed ID: 37435838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.
    Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S;
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
    Kim HS; Kang J; Hwang D; Han JK; Yang HM; Kang HJ; Koo BK; Rhew JY; Chun KJ; Lim YH; Bong JM; Bae JW; Lee BK; Park KW;
    Lancet; 2020 Oct; 396(10257):1079-1089. PubMed ID: 32882163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Guo C; Li M; Lv YH; Zhang MB; Wang ZL
    Platelets; 2020; 31(1):15-25. PubMed ID: 30759033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials.
    Abdelazeem B; Shehata J; Abbas KS; El-Shahat NA; Baral N; Adhikari G; Khan H; Hassan M
    Am J Cardiovasc Drugs; 2022 May; 22(3):287-298. PubMed ID: 34651261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.
    Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Gori T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Thalmeier A; Löw A; Holdt L; Teupser D; Ince H; Felix SB; Parma R; Malek L; Horstkotte J; Baylacher M; Schwinger R; Rieber J; Mudra H; Hausleiter J; Huber K; Neumann FJ; Koltowski L; Huczek Z; Mehilli J; Massberg S;
    Thromb Haemost; 2017 Jan; 117(1):188-195. PubMed ID: 27652610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Kang J; Rizas KD; Park KW; Chung J; van den Broek W; Claassens DMF; Choo EH; Aradi D; Massberg S; Hwang D; Han JK; Yang HM; Kang HJ; Chang K; Ten Berg JM; Sibbing D; Koo BK; Kim HS
    Eur Heart J; 2023 Apr; 44(15):1360-1370. PubMed ID: 36883613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivors of out-of-hospital cardiac arrest treated with percutaneous coronary intervention: Thrombotic and bleeding events among different oral P2Y
    Picard F; Laghlam D; Diefenbronn M; Seret G; Varenne O; Dumas F; Cariou A
    Arch Cardiovasc Dis; 2021; 114(8-9):577-587. PubMed ID: 34257048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
    Capodanno D; Mehran R; Krucoff MW; Baber U; Bhatt DL; Capranzano P; Collet JP; Cuisset T; De Luca G; De Luca L; Farb A; Franchi F; Gibson CM; Hahn JY; Hong MK; James S; Kastrati A; Kimura T; Lemos PA; Lopes RD; Magee A; Matsumura R; Mochizuki S; O'Donoghue ML; Pereira NL; Rao SV; Rollini F; Shirai Y; Sibbing D; Smits PC; Steg PG; Storey RF; Ten Berg J; Valgimigli M; Vranckx P; Watanabe H; Windecker S; Serruys PW; Yeh RW; Morice MC; Angiolillo DJ
    Circulation; 2023 Jun; 147(25):1933-1944. PubMed ID: 37335828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational Study.
    Wang HY; Dou KF; Guan C; Xie L; Huang Y; Zhang R; Yang W; Wu Y; Yang Y; Qiao S; Gao R; Xu B
    Circ Cardiovasc Interv; 2022 Jun; 15(6):e011536. PubMed ID: 35582961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing Benefits and Risks of Oral Antiplatelet Strategies in patients With Coronary Artery Diseases: An Evolving Issue.
    De Luca L; Gragnano F; Calabrò P; Huber K
    Curr Probl Cardiol; 2023 Dec; 48(12):102025. PubMed ID: 37553063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention].
    Gragnano F; Capolongo A; Terracciano F; Gargiulo G; Cesaro A; Moscarella E; De Sio V; Patti G; Porto I; Esposito G; Calabrò P
    G Ital Cardiol (Rome); 2023 Feb; 24(2):99-109. PubMed ID: 36735308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y
    Sibbing D; Aradi D; Alexopoulos D; Ten Berg J; Bhatt DL; Bonello L; Collet JP; Cuisset T; Franchi F; Gross L; Gurbel P; Jeong YH; Mehran R; Moliterno DJ; Neumann FJ; Pereira NL; Price MJ; Sabatine MS; So DYF; Stone GW; Storey RF; Tantry U; Trenk D; Valgimigli M; Waksman R; Angiolillo DJ
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1521-1537. PubMed ID: 31202949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
    Kuno T; Watanabe A; Shoji S; Fujisaki T; Ueyama H; Takagi H; Deharo P; Cuisset T; Bangalore S; Mehran R; Stone GW; Kohsaka S; Bhatt DL
    Circ Cardiovasc Interv; 2023 Sep; 16(9):e013242. PubMed ID: 37609850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.